CoChat

Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

In cortisone reductase deficiency (CRD), activation of cortisone to cortisol does not occur, resulting in adrenocorticotropin-mediated androgen excess and a phenotype resembling polycystic ovary syndrome (PCOS; refs. 1,2). This suggests a defect in the gene HSD11B1 encoding 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), a primary regulator of tissue-specific glucocorticoid bioavailability. We identified intronic mutations in HSD11B1 that resulted in reduced gene transcription in three individuals with CRD. In vivo, 11beta-HSD1 catalyzes the reduction of cortisone to cortisol whereas purified enzyme acts as a dehydrogenase converting cortisol to cortisone. Oxo-reductase activity can be regained using a NADPH-regeneration system and the cytosolic enzyme glucose-6-phosphate dehydrogenase. But the catalytic domain of 11beta-HSD1 faces into the lumen of the endoplasmic reticulum (ER; ref. 6). We hypothesized that endolumenal hexose-6-phosphate dehydrogenase (H6PDH) regenerates NADPH in the ER, thereby influencing directionality of 11beta-HSD1 activity. Mutations in exon 5 of H6PD in individuals with CRD attenuated or abolished H6PDH activity. These individuals have mutations in both HSD11B1 and H6PD in a triallelic digenic model of inheritance, resulting in low 11beta-HSD1 expression and ER NADPH generation with loss of 11beta-HSD1 oxo-reductase activity. CRD defines a new ER-specific redox potential and establishes H6PDH as a potential factor in the pathogenesis of PCO…

Overview

Integrity signals

Registry

Crossref · 10.1038/ng1214

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 288

Metadata

Authors
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., Malunowicz, E., White, P. C., Hewison, M., Mason, P. J., Connell, J. M., Shackleton, C. H. L., & Stewart, P. M.
Affiliations
  • Queen Elizabeth Hospital Birmingham (GB)
  • University of Manchester (GB)
  • Manchester Royal Infirmary (GB)
  • The University of Texas Southwestern Medical Center (US)
  • Hammersmith Hospital (GB)
  • University of Glasgow (GB)
  • UCSF Benioff Children's Hospital (US)
Corresponding author
Stewart, Paul M
Venue
Nature Genetics
Published
2003-07-13
Volume
34
Issue
4
Pages
434-439
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2104167472
Cited by
285
References
33
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 5 · 2014: 12 · 2013: 14 · 2012: 22
FWCI
15.50
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders
  • University Hospitals Birmingham NHS Foundation Trust
  • University of Birmingham
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
11β-hydroxysteroid dehydrogenase type 1, hexose-6-phosphate dehydrogenase, intronic variants, NADPH regeneration, endoplasmic reticulum, glucocorticoid metabolism, ACTH, hyperandrogenism, polycystic ovary syndrome, digenic inheritance, gene transcription
MeSH terms
Amino Acid Sequence, Base Sequence, Carbohydrate Dehydrogenases, Cell Line, Cortisone Reductase, Endoplasmic Reticulum, Exons, Female, Humans, Hydroxysteroid Dehydrogenases, Male, Molecular Sequence Data, Mutation, NADP, Oxidation-Reduction, Phenotype, Polycystic Ovary Syndrome, RNA, Messenger, Transfection, Case-Control Studies, Sequence Homology, Amino Acid, DNA, Complementary, 11-beta-Hydroxysteroid Dehydrogenase Type 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.